Joseph Rus
Director/Board Member at BELLUS HEALTH
Network origin in Joseph Rus first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986
32
| Extinct | Miscellaneous Commercial Services | 32 |
| Subsidiary | Pharmaceuticals: Major | 30 | |
Shire Acquisition, Inc.
 Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is the researching, development and marketing of prescription medicines. The Group operations focuses on three therapeutic areas - central nervous system disorders, gastrointestinal and renal diseases. The Group's marketed products for such disorders include ADDERALL and ADDERALL XR, for attention deficit hyperactivity disorder, REMINYL for Alzheimer's, co-marketed with Johnson and Johnson and CARBATROL. for epilepsy. The Group is also developing a range of treatments for ADHD which may treat children, adolescents and adults extending the use of its current brand as well as researching non-scheduled compounds. The Group operates in the United Kingdom, the United States of America, France, Germany, Italy, Spain, Ireland, Canada, the Netherlands and the Cayman Islands.
15
| Extinct | Pharmaceuticals: Major | 15 |
Adaltis, Inc.
 Adaltis, Inc. Pharmaceuticals: MajorHealth Technology Adaltis, Inc. is an international in-vitro diagnostic company. The company develops, manufactures and markets in-vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases and measure human hormone responses. Adaltis was founded on June 12, 1987 and is headquartered in Montreal, Canada.
15
| Extinct | Pharmaceuticals: Major | 15 |
| Extinct | Pharmaceuticals: Major | 9 | |
Envoy Capital Group, Inc.
 Envoy Capital Group, Inc. Advertising/Marketing ServicesCommercial Services Envoy Capital Group, Inc. is a merchant banking company. It provides financial services as well as equity and debt capital to small and mid-cap companies. The firm has two segments: Merchant Banking and Consumer & Retail Branding. The company was founded in December 1993 and is headquartered in Toronto, ON.
4
| Extinct | Advertising/Marketing Services | 4 |
Shire BioChem, Inc.
 Shire BioChem, Inc. Medical DistributorsDistribution Services Shire BioChem, Inc. provides pharmaceutical sales and marketing services in Canada. The company is headquartered in Laval, Canada.
2
| Subsidiary | Medical Distributors | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joseph Rus via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President Chairman Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member President | |
| POWER CORPORATION OF CANADA | Multi-Line Insurance | Corporate Officer/Principal Chief Investment Officer | |
| FIRM CAPITAL APARTMENT REAL ESTATE INVESTMENT TRUST | Real Estate Investment Trusts | Director of Finance/CFO Director of Finance/CFO | |
| SHIRE | Pharmaceuticals: Major | Chief Administrative Officer Chairman Director/Board Member Director/Board Member Director/Board Member Public Communications Contact Chief Executive Officer Director/Board Member General Counsel Corporate Officer/Principal Director/Board Member Director/Board Member Public Communications Contact | |
| ALZHEON, INC. | Biotechnology | Director/Board Member Chairman Founder | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Picchio Pharma, Inc.
 Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Picchio Pharma, Inc. engages in acquiring, developing, and commercializing new therapeutic products and technologies. The company was founded in 2001 and is headquartered in Laval, Canada. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Concordia University | College/University | Undergraduate Degree Director/Board Member Chairman Undergraduate Degree | |
| Fairleigh Dickinson University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| The Johns Hopkins University | College/University | Graduate Degree Director/Board Member Graduate Degree Graduate Degree | |
| University of Alberta | College/University | Undergraduate Degree Graduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Western Ontario | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree Doctorate Degree | |
| University of Montréal | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Durham | College/University | Undergraduate Degree Graduate Degree | |
| Georgetown University | College/University | Undergraduate Degree Undergraduate Degree | |
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Bishop's University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| London Business School | College/University | President Masters Business Admin | |
| THALLION PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Corporate Officer/Principal | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | President Corporate Officer/Principal | |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Corporate Officer/Principal General Counsel General Counsel | |
Victoria Square Ventures, Inc.
 Victoria Square Ventures, Inc. Investment ManagersFinance Part of Power Corp. of Canada, Victoria Square Ventures, Inc. is a Canadian company that provides investment services. The company is based in Montréal, Canada. Olivier André Desmarais has been the CEO of the company since 2018. | Investment Managers | Chief Executive Officer Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Merus Labs, Inc.
 Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Part of Norgine Europe BV, Merus Labs, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Vancouver, Canada. The company was founded by Penny White, Ahmad Doroudian. Paul William Pay has been the CEO of the company since 2017. Merus Labs was acquired by Range Gold Corp. on March 26, 2010. | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO | |
Eagle Creek Renewable Energy LLC
 Eagle Creek Renewable Energy LLC Electric UtilitiesUtilities Eagle Creek Renewable Energy LLC owns, operates and develops hydroelectric and biomass power projects. It offers operations, maintenance, regulatory, repair and overhaul services to own facilities and other hydroelectric facilities. The company was founded in 2010 and is headquartered in Morristown, NJ. | Electric Utilities | Director/Board Member Director/Board Member | |
Potentia Renewables, Inc.
 Potentia Renewables, Inc. Alternative Power GenerationUtilities Potentia Renewables, Inc. operates as an independent power producer. It owns and operates solar photovoltaic energy systems for rooftop and ground installation. The company was founded by Daniel Argiros in 2010 and is headquartered in Toronto, Canada. | Alternative Power Generation | Director/Board Member Director/Board Member | |
Power Sustainable Capital Inc
 Power Sustainable Capital Inc Investment ManagersFinance Power Sustainable Capital Inc (Power Sustainable Capital) is a private equity firm headquartered in Montréal. The firm is founded in 2012, subsidiary of Power Corp of Canada. | Investment Managers | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
| Université du Québec à Montréal | College/University | Graduate Degree Undergraduate Degree |
Statistics
International
| Canada | 25 |
| United States | 18 |
| United Kingdom | 6 |
| Ireland | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 18 |
| Finance | 5 |
| Commercial Services | 5 |
| Utilities | 3 |
Operational
| Director/Board Member | 500 |
| Corporate Officer/Principal | 205 |
| Independent Dir/Board Member | 117 |
| Chairman | 114 |
| President | 97 |
Most connected contacts
| Insiders | |
|---|---|
| Jeffrey Leiden | 43 |
| Franklin Berger | 41 |
| James Cavanaugh | 38 |
| Chau Khuong | 38 |
| Michael Rosenblatt | 31 |
| Randal Chase | 28 |
| Peter Kruyt | 28 |
| Michelle Cormier | 27 |
| Francesco Bellini | 27 |
| Pierre Larochelle | 26 |
| Neil William Flanzraich | 25 |
| Sylvie Grégoire | 25 |
| Richard Renaud | 24 |
| Donald Sheldon | 23 |
| Patrick J. Langlois | 23 |
- Stock Market
- Insiders
- Joseph Rus
- Company connections
